Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Study to compare the detection of neoplastic lesions between chromoendoscopy and NBI
Single-blind (patient) randomized study to compare detection of neoplastic lesions between chromoendoscopy and NBI.
Patients with Inflammatory Bowel Disease who are to undergo chromoendoscopy according to usual clinical criteria will be included. The endoscopic procedure is similar to the one usually performed. All patients will undergo colonoscopy according to the usual procedure, with Olympus HQ190 series endoscopes, with the same bowel preparation. During intubation, the faecal remains will be thoroughly washed.
Patients will be randomly assigned to one of the two techniques: Chromoendoscopy with 0.1% methylene blue or New generation NBI with Near focus.
Biopsies will be taken of all those lesions detected, instead of random biopsies.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Chromoendoscopy with methylene blue 0.1% | Active Comparator | Once the cecum is reached, a spray catheter is introduced through the working channel and the dye, a 0.1% methylene blue solution, is applied. |
|
| Virtual Chromoendoscopy with NBI with HQ190 endoscopes | Experimental | Intubation is done with normal white light. Once the cecum is reached, the removal will be done in NBI mode |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Chromoendoscopy | Procedure | Chromoendoscopy is an endoscopic technique used in the follow-up of inflammatory bowel disease of long evolution. Chromoendoscopy, through the application of specific dyes used directly on the intestinal mucosa, promotes the visualization of mucosal lesions. |
| Measure | Description | Time Frame |
|---|---|---|
| Lesions detected | Total number of IBD dysplastic lesions detected by the use of NBI virtual chromoendoscopy versus conventional chromoendoscopy | Baseline |
| Measure | Description | Time Frame |
|---|---|---|
| Detection rate of dysplastic lesions | Number of patients with at least one dysplastic lesion | Baseline |
| Non-dysplastic lesions | Assess the number of non-dysplastic lesions detected with both methods |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Eduardo MartÃn Arranz, PhD | Contact | +34912071350 | emarranz@salud.madrid.org |
| Name | Affiliation | Role |
|---|---|---|
| Eduardo MartÃn Arranz, PhD | Hospital Universitario La Paz | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Hospital Universitario La Paz | Recruiting | Madrid | 28046 | Spain |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
|
| Baseline |
| Ratio of neoplastic lesions/total lesions | Compare the ratio of neoplastic lesions/total lesions between both groups | Baseline |
| Total endoscopy time | The total endoscopy time is counted from the introduction of the endoscope in the patient until its complete removal | Baseline |
| Removal time | Withdrawal time is counted from the time the cecum is reached to the completion of the test, including time spent on staining, biopsy or polypectomy | Baseline |
| Near Focus ability | Assess Near Focus ability to optically differentiate dysplastic from non-dysplastic lesions | Baseline |
| Number of biopsies | Number of biopsies taken in the different groups | Baseline |